Advanced Proteome Therapeutics Corporation: Difference between revisions
(Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company...") |
(No difference)
|
Latest revision as of 00:29, 17 August 2022
Summary[1]Edit
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.
References and notesEdit
- ↑ Source: Yahoo Finance.